In the News: November 2016

Many people with rheumatoid arthritis take biologic drugs, which differ from traditional drugs in that they are produced by living cells. This makes it difficult to produce cheaper generic versions. Biosimilar drugs, which are approximate copies that have the same therapeutic effect, have been created to replace traditional generic drugs. In a study published in August 2016, researchers analyzed results of 19 studies of five biologic drugs and their biosimilar counterparts.
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Arthritis Advisor

Get the next year of Arthritis Advisor for just $20. And access all of our online content - over 1,000 articles - free of charge.
Subscribe today and save 36%. It's like getting 4 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access